Wikisage, the free encyclopedia of the second generation and digital heritage, wishes you merry holidays and a happy new year!
Cyclophosphamide: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
as immunesupressor is used in nephortic syndrome, [[Churg-Strauss_syndrome| granulomatosis]] and following organ transplant. <ref>[https://www.tandfonline.com/doi/abs/10.1080/17474086.2017.1318054?journalCode=ierr20 Post-transplant cyclophosphamide, a promising anti-graft versus host disease prophylaxis: where do we stand?]</ref><ref>[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724335/ Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients]</ref> | as immunesupressor is used in nephortic syndrome, [[Churg-Strauss_syndrome| granulomatosis]] and following organ transplant. <ref>[https://www.tandfonline.com/doi/abs/10.1080/17474086.2017.1318054?journalCode=ierr20 Post-transplant cyclophosphamide, a promising anti-graft versus host disease prophylaxis: where do we stand?]</ref><ref>[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724335/ Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients]</ref> | ||
<gallery>File:Cc-R-cyclophosphamide-from-xtal-1996-3D-balls.png</gallery> | <ref>[http://www.haematologica.org/content/104/10/e478.long T-Cell Replete Haploidentical Bone Marrow Transplantation And Post-Transplant Cyclophosphamide For Patients With Inborn Errors]</ref> | ||
<gallery> | |||
File:Cc-R-cyclophosphamide-from-xtal-1996-3D-balls.png | |||
</gallery> | |||
{{Reflist}} | {{Reflist}} | ||
{{Wikidata|Q408524}} | {{Wikidata|Q408524}} | ||
Revision as of 00:12, 19 October 2019
as immunesupressor is used in nephortic syndrome, granulomatosis and following organ transplant. [1][2] [3]
- ↑ Post-transplant cyclophosphamide, a promising anti-graft versus host disease prophylaxis: where do we stand?
- ↑ Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients
- ↑ T-Cell Replete Haploidentical Bone Marrow Transplantation And Post-Transplant Cyclophosphamide For Patients With Inborn Errors
